Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part II-Ocular drug-loaded lipid nanoparticles

E Sánchez-López, M Espina, S Doktorovova… - European Journal of …, 2017 - Elsevier
In the recent decades, various controlled delivery systems have been introduced with the
aim to improve solubility, stability and bioavailability of poorly absorbed drugs. Among all …

[引用][C] Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part II-Ocular drug-loaded lipid nanoparticles

E Sánchez-López, M Espina, S Doktorovova… - European Journal of …, 2017 - cir.nii.ac.jp
Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the
eye – Part II - Ocular drug-loaded lipid nanoparticles | CiNii Research CiNii 国立情報学研究所 …

Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye-Part II-Ocular drug-loaded lipid nanoparticles.

E Sánchez-López, M Espina… - European Journal of …, 2016 - europepmc.org
In the recent decades, various controlled delivery systems have been introduced with the
aim to improve solubility, stability and bioavailability of poorly absorbed drugs. Among all …

Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part II-Ocular drug-loaded lipid nanoparticles

E Sánchez-López, M Espina, S Doktorovova… - European Journal of …, 2017 - infona.pl
In the recent decades, various controlled delivery systems have been introduced with the
aim to improve solubility, stability and bioavailability of poorly absorbed drugs. Among all …

Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye-Part II-Ocular drug-loaded lipid nanoparticles

E Sánchez-López, M Espina… - … : official journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
In the recent decades, various controlled delivery systems have been introduced with the
aim to improve solubility, stability and bioavailability of poorly absorbed drugs. Among all …